The Effects of Low HER2/neu Expression on the Clinicopathological Characteristics of Triple-Negative Breast Cancer Patients.

Mehdi DehghaniPedram KeshavarzAbdolrasoul TaleiMajid AkramiSedighe TahmasebiAkbar SafaieMaryam Ghanbari

Published in: Asian Pacific journal of cancer prevention : APJCP (2020)

The findings revealed that patients with HER22+ had better outcome in comparison to the patients with HER20 and HER21+. Furthermore, the results showed that many patients with HER22+ expression were not basal-like and had good prognosis amongst TNBC patients.

Keyphrases

poor prognosis
end stage renal disease
newly diagnosed
chronic kidney disease
ejection fraction
prognostic factors
binding protein
peritoneal dialysis
long non coding rna